Clinical trials
Phase 2 Central Nervous System Neoplasms trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 8 |
| UNICANCER | 2 |
| Celgene | 1 |
| Children's Cancer and Leukaemia Group | 1 |
| Gustave Roussy, Cancer Campus, Grand Paris | 1 |
| Incyte Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 14 |
| Glioblastoma | 7 |
| Brain Neoplasms | 6 |
| Oligodendroglioma | 6 |
| Glioma | 5 |
| Gliosarcoma | 5 |
| Astrocytoma | 3 |
| Medulloblastoma | 2 |
| Carcinoma, Neuroendocrine | 1 |
| Ependymoma | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.